RT Conference Proceedings
T1 ARE THERE ANY DIFFERENCES IN THE EFFECTIVITY AND SAFETY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS ACCORDING THEIR GENDER?
A1 Garcia, Rosa
A1 Fernandez-Prada, Manuel
A1 Conesa, Arantxa
A1 Campos Esteban, Jose
A1 Urruticoechea-Arana, Ana
A1 Olive, Alejandro
A1 Paredes, Silvia
A1 Taverner, Delia
A1 Gonzalez, Carlos
A1 RENACER, 
PB Bmj publishing group
SN 0003-4967
YR 2019
FD 2019-06-01
LK https://hdl.handle.net/10668/26894
UL https://hdl.handle.net/10668/26894
LA en
DS RISalud
RD Apr 18, 2025